Free Trial

Vaccinex (VCNX) Competitors

Vaccinex logo
$0.68 +0.02 (+3.09%)
As of 03:47 PM Eastern

VCNX vs. ACXP, BMRA, BCLI, PHIO, BTAI, NEUP, ADXN, SNSE, PRTG, and AIMD

Should you be buying Vaccinex stock or one of its competitors? The main competitors of Vaccinex include Acurx Pharmaceuticals (ACXP), Biomerica (BMRA), Brainstorm Cell Therapeutics (BCLI), Phio Pharmaceuticals (PHIO), BioXcel Therapeutics (BTAI), Neuphoria Therapeutics Inc. - Common Stock (NEUP), Addex Therapeutics (ADXN), Sensei Biotherapeutics (SNSE), Portage Biotech (PRTG), and Ainos (AIMD). These companies are all part of the "pharmaceutical products" industry.

Vaccinex vs.

Acurx Pharmaceuticals (NASDAQ:ACXP) and Vaccinex (NASDAQ:VCNX) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, media sentiment, valuation, community ranking, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Acurx Pharmaceuticals has higher earnings, but lower revenue than Vaccinex. Acurx Pharmaceuticals is trading at a lower price-to-earnings ratio than Vaccinex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acurx PharmaceuticalsN/AN/A-$14.58M-$0.70-0.56
Vaccinex$388K6.50-$20.25M-$48.27-0.02

Vaccinex's return on equity of 0.00% beat Acurx Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Acurx PharmaceuticalsN/A -392.36% -223.78%
Vaccinex N/A N/A -383.58%

Vaccinex received 106 more outperform votes than Acurx Pharmaceuticals when rated by MarketBeat users. However, 94.44% of users gave Acurx Pharmaceuticals an outperform vote while only 60.00% of users gave Vaccinex an outperform vote.

CompanyUnderperformOutperform
Acurx PharmaceuticalsOutperform Votes
17
94.44%
Underperform Votes
1
5.56%
VaccinexOutperform Votes
123
60.00%
Underperform Votes
82
40.00%

Acurx Pharmaceuticals presently has a consensus price target of $8.00, indicating a potential upside of 1,951.28%. Given Acurx Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe Acurx Pharmaceuticals is more favorable than Vaccinex.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Acurx Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Vaccinex
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

11.5% of Acurx Pharmaceuticals shares are owned by institutional investors. Comparatively, 50.1% of Vaccinex shares are owned by institutional investors. 29.6% of Acurx Pharmaceuticals shares are owned by company insiders. Comparatively, 51.5% of Vaccinex shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Acurx Pharmaceuticals had 5 more articles in the media than Vaccinex. MarketBeat recorded 5 mentions for Acurx Pharmaceuticals and 0 mentions for Vaccinex. Acurx Pharmaceuticals' average media sentiment score of 0.55 beat Vaccinex's score of 0.00 indicating that Acurx Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
Acurx Pharmaceuticals Positive
Vaccinex Neutral

Acurx Pharmaceuticals has a beta of -1.37, meaning that its stock price is 237% less volatile than the S&P 500. Comparatively, Vaccinex has a beta of 1.1, meaning that its stock price is 10% more volatile than the S&P 500.

Summary

Acurx Pharmaceuticals beats Vaccinex on 9 of the 16 factors compared between the two stocks.

Get Vaccinex News Delivered to You Automatically

Sign up to receive the latest news and ratings for VCNX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VCNX vs. The Competition

MetricVaccinexPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$2.52M$6.47B$5.32B$8.44B
Dividend YieldN/A2.64%5.21%4.11%
P/E Ratio-0.029.0726.8119.78
Price / Sales6.50255.02387.95118.50
Price / CashN/A65.8538.2534.62
Price / Book-0.376.436.774.52
Net Income-$20.25M$143.98M$3.23B$248.32M
7 Day Performance-6.73%2.34%1.73%0.58%
1 Month Performance29.33%4.47%10.92%13.09%
1 Year Performance-82.65%-2.70%17.16%7.74%

Vaccinex Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VCNX
Vaccinex
N/A$0.68
+3.1%
N/A-87.8%$1.77M$388,000.00-0.0140Gap Up
ACXP
Acurx Pharmaceuticals
2.5847 of 5 stars
$0.41
+4.7%
$8.00
+1,874.8%
-85.3%$9.51MN/A-0.373Analyst Revision
High Trading Volume
BMRA
Biomerica
0.1521 of 5 stars
$3.60
-1.1%
N/A-33.3%$9.17M$5.68M-10.5960News Coverage
BCLI
Brainstorm Cell Therapeutics
3.9586 of 5 stars
$1.36
+3.0%
$30.00
+2,105.9%
-87.3%$8.87MN/A-0.2840Earnings Report
Analyst Forecast
Gap Up
High Trading Volume
PHIO
Phio Pharmaceuticals
2.9373 of 5 stars
$1.83
-0.5%
$4.00
+118.6%
-73.8%$8.74MN/A-0.1710Positive News
BTAI
BioXcel Therapeutics
3.9351 of 5 stars
$1.44
-0.7%
$42.60
+2,858.3%
-95.7%$8.72M$1.85M-0.0490
NEUP
Neuphoria Therapeutics Inc. - Common Stock
1.546 of 5 stars
$4.92
flat
$21.00
+326.8%
N/A$8.64M$662,715.000.00N/ANews Coverage
Positive News
Earnings Report
Gap Up
ADXN
Addex Therapeutics
1.6732 of 5 stars
$8.10
-0.3%
$30.00
+270.6%
-5.6%$8.58M$556,045.00-23.8130Gap Up
SNSE
Sensei Biotherapeutics
3.9201 of 5 stars
$0.33
-4.1%
$4.25
+1,187.9%
-77.1%$8.32MN/A-0.2840
PRTG
Portage Biotech
0.2987 of 5 stars
$7.99
+1.3%
N/A+61.1%$8.28MN/A-0.196Upcoming Earnings
Gap Up
AIMD
Ainos
0.4889 of 5 stars
$0.53
-2.9%
N/A-51.6%$8.15M$20,729.00-0.4140News Coverage
Gap Down

Related Companies and Tools


This page (NASDAQ:VCNX) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners